Piper Sandler Initiates Coverage On Innoviva with Overweight Rating, Announces Price Target of $29

Benzinga · 1d ago
Piper Sandler analyst David Amsellem initiates coverage on Innoviva (NASDAQ:INVA) with a Overweight rating and announces Price Target of $29.